Assenagon Asset Management S.A. Has $6.70 Million Holdings in Oscar Health, Inc. (NYSE:OSCR)

→ READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad)

Assenagon Asset Management S.A. lowered its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 30.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 732,285 shares of the company's stock after selling 327,244 shares during the period. Assenagon Asset Management S.A. owned approximately 0.32% of Oscar Health worth $6,700,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in OSCR. Envestnet Asset Management Inc. purchased a new position in shares of Oscar Health during the 1st quarter worth approximately $164,000. Advisor Group Holdings Inc. boosted its position in shares of Oscar Health by 157.5% during the 1st quarter. Advisor Group Holdings Inc. now owns 10,106 shares of the company's stock worth $101,000 after purchasing an additional 6,182 shares during the period. Swiss National Bank boosted its position in shares of Oscar Health by 8.6% during the 1st quarter. Swiss National Bank now owns 103,100 shares of the company's stock worth $1,028,000 after purchasing an additional 8,200 shares during the period. Ergoteles LLC purchased a new position in shares of Oscar Health during the 1st quarter worth approximately $633,000. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Oscar Health by 2.5% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 193,504 shares of the company's stock worth $1,930,000 after purchasing an additional 4,801 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.


Oscar Health Stock Up 4.6 %

Shares of OSCR traded up $0.66 during midday trading on Friday, reaching $14.87. The stock had a trading volume of 4,073,649 shares, compared to its average volume of 2,902,570. Oscar Health, Inc. has a 1-year low of $4.72 and a 1-year high of $18.55. The company's fifty day simple moving average is $14.75 and its two-hundred day simple moving average is $9.93. The company has a market cap of $3.42 billion, a price-to-earnings ratio of -12.39 and a beta of 1.82. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.19 and a quick ratio of 1.19.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, beating analysts' consensus estimates of ($0.74) by $0.08. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period last year, the business earned ($1.05) EPS. The company's revenue was up 43.9% on a year-over-year basis. Equities research analysts expect that Oscar Health, Inc. will post -0.23 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on OSCR shares. TheStreet upgraded shares of Oscar Health from a "d" rating to a "c-" rating in a report on Wednesday, February 21st. Wells Fargo & Company increased their target price on shares of Oscar Health from $12.00 to $20.00 and gave the stock an "overweight" rating in a report on Thursday, February 15th. Raymond James started coverage on shares of Oscar Health in a report on Friday, March 22nd. They set an "outperform" rating and a $20.00 target price on the stock. Finally, The Goldman Sachs Group increased their target price on shares of Oscar Health from $8.00 to $16.00 and gave the stock a "neutral" rating in a report on Friday, February 9th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $13.50.

View Our Latest Research Report on OSCR

Oscar Health Company Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Read More

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

→ READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Oscar Health right now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: